Cargando…

Efficacy and Safety of Efalizumab in Patients with Moderate-to-Severe Plaque Psoriasis Resistant to Previous Anti-Psoriatic Treatment: Results of a Multicentre, Open-label, Phase IIIb/IV Trial

OBJECTIVES: To evaluate the efficacy and safety of efalizumab in continuous or interrupted therapy of adults with moderate-to-severe plaque psoriasis who had failed to respond to or were intolerant of other systemic therapies, including methotrexate, ciclosporin and psoralen plus UVA phototherapy, o...

Descripción completa

Detalles Bibliográficos
Autores principales:	Lotti, Torello, Chimenti, Sergio, Katsambas, Andreas, Ortonne, Jean-Paul, Dubertret, Louis, Licu, Daiana, Simon, Jan
Formato:	Texto
Lenguaje:	English
Publicado:	Blackwell Publishing Inc 2010
Materias:	Original Articles
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC2855833/ https://www.ncbi.nlm.nih.gov/pubmed/20428228 http://dx.doi.org/10.1111/j.1753-5174.2009.00026.x

Ejemplares similares

Assessing the Impact of Efalizumab on Nail, Scalp and Palmoplantar Psoriasis and on Quality of Life: Results from a Multicentre, Open-label, Phase IIIb/IV Trial
por: Katsambas, Andreas, et al.
Publicado: (2009)

Control of Moderate-to-Severe Plaque Psoriasis with Efalizumab: 24-Week, Open-Label, Phase IIIb/IV Latin American Study Results
por: Stengel, Fernando M, et al.
Publicado: (2009)

Efalizumab in the treatment of psoriasis
por: Boehncke, Wolf-Henning
Publicado: (2007)

Efalizumab in the Treatment of Scalp, Palmoplantar and Nail Psoriasis: Results of a 24-Week Latin American Study
por: Takahashi, María Denise, et al.
Publicado: (2010)

Evaluation of efalizumab using safe psoriasis control
por: Papp, Kim A, et al.
Publicado: (2006)

Efalizumab-induced severe thrombocytopenia can be resolved
por: Prignano, Francesca, et al.
Publicado: (2008)

Betamethasone valerate dressing is non-inferior to calcipotriol–betamethasone dipropionate ointment in the treatment of patients with mild-to-moderate chronic plaque psoriasis: results of a randomized assessor-blinded multicentre trial
por: Ortonne, J-P, et al.
Publicado: (2014)

Impact of efalizumab on patient-reported outcomes in high-need psoriasis patients: results of the international, randomized, placebo-controlled Phase III Clinical Experience Acquired with Raptiva (CLEAR) trial [NCT00256139]
por: Ortonne, Jean-Paul, et al.
Publicado: (2005)

Efficacy and Safety of Dimethyl Fumarate in Patients with Moderate-to-Severe Plaque Psoriasis: DIMESKIN-2, a Multicentre Single-Arm Phase IIIb Study
por: Pellacani, Giovanni, et al.
Publicado: (2022)

Fibroblasts to Keratinocytes Redox Signaling: The Possible Role of ROS in Psoriatic Plaque Formation
por: Barygina, Victoria, et al.
Publicado: (2019)

Efalizumab: results of a 3-year continuous dosing study for the long-term control of psoriasis
por: Leonardi, C, et al.
Publicado: (2008)

Psoriasis vulgaris flare during efalizumab therapy does not preclude future use: a case series
por: Lowes, Michelle A, et al.
Publicado: (2005)

Contemporary treatment patterns in plaque psoriasis and psoriatic arthritis
por: Jenerowicz, Dorota, et al.
Publicado: (2020)

Eruptive papules during efalizumab (anti-CD11a) therapy of psoriasis vulgaris: a case series
por: Lowes, Michelle A, et al.
Publicado: (2007)

Multicentric Squamous Cell Carcinoma Arising on Psoriatic Plaque
por: Gupta, Megha, et al.
Publicado: (2013)

Genetic screening test for psoriatic arthritis and UVB irradiation potential responders: A new tool to identify psoriasis subpopulation patients?
por: Lotti, Torello, et al.
Publicado: (2011)

Infliximab in the treatment of plaque type psoriasis
por: Saraceno, Rosita, et al.
Publicado: (2009)

Efficacy and Safety of Secukinumab in Chronic Plaque Psoriasis and Psoriatic Arthritis Therapy
por: Gisondi, Paolo, et al.
Publicado: (2014)

S100A8/A9 in psoriatic plaques from patients with psoriatic arthritis
por: Chimenti, Maria Sole, et al.
Publicado: (2016)

Moderate and severe plaque psoriasis: cost-of-illness study in Italy
por: Colombo, GL, et al.
Publicado: (2008)

Spotlight on ixekizumab for the treatment of moderate-to-severe plaque psoriasis: design, development, and use in therapy
por: Giunta, Alessandro, et al.
Publicado: (2017)

Sirt1 Protects against Oxidative Stress-Induced Apoptosis in Fibroblasts from Psoriatic Patients: A New Insight into the Pathogenetic Mechanisms of Psoriasis
por: Becatti, Matteo, et al.
Publicado: (2018)

Approaches to discontinuing efalizumab: an open-label study of therapies for managing inflammatory recurrence
por: Papp, Kim A, et al.
Publicado: (2006)

The incidence of arthropathy adverse events in efalizumab-treated patients is low and similar to placebo and does not increase with long-term treatment: pooled analysis of data from Phase III clinical trials of efalizumab
por: Pincelli, Carlo, et al.
Publicado: (2006)

Prevalence of psoriatic arthritis among patients with plaque psoriasis: a Brazilian retrospective study
por: Gamonal, Shirley Braga Lima, et al.
Publicado: (2021)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential
por: Chiricozzi, Andrea, et al.
Publicado: (2019)

Use of Curcumin in Psoriasis
por: Nardo, Veronica Di, et al.
Publicado: (2018)

Immunohistochemical study of psoriatic plaques and perilesional skin in psoriasis vulgaris patients: A pilot study
por: Morar, Iulia-Ioana, et al.
Publicado: (2019)

Use of IL-23 Inhibitors for the Treatment of Plaque Psoriasis and Psoriatic Arthritis: A Comprehensive Review
por: Yang, Kevin, et al.
Publicado: (2020)

Treatment of Psoriasis: Novel Approaches to Topical Delivery
por: Wollina, Uwe, et al.
Publicado: (2019)

Emerging treatment options for the treatment of moderate to severe plaque psoriasis and psoriatic arthritis: evaluating bimekizumab and its therapeutic potential [Corrigendum]
Publicado: (2019)

Secondary Syphilis Presenting As Palmoplantar Psoriasis
por: Gianfaldoni, Serena, et al.
Publicado: (2017)

A strange infiltrative plaque on the face
por: Guarneri, Claudio, et al.
Publicado: (2015)

Umbilical Plaque in Psoriatic Arthritis
por: Nagashima, Takao, et al.
Publicado: (2017)

Early identification of axial psoriatic arthritis among patients with psoriasis: a prospective multicentre study
por: Proft, Fabian, et al.
Publicado: (2022)

Association of Toll-like receptor 4 (TLR4) with chronic plaque type psoriasis and psoriatic arthritis
por: Smith, Rh. Ll., et al.
Publicado: (2016)

Predicting the Risk of Psoriatic Arthritis in Plaque Psoriasis Patients: Development and Assessment of a New Predictive Nomogram
por: Liu, Panpan, et al.
Publicado: (2022)

Phase I study of high-dose epirubicin and vinorelbine in previously untreated non-small-cell lung cancer stage IIIB-IV.
por: Bakker, M., et al.
Publicado: (1995)

GENETICS OF PSORIASIS AND PSORIATIC ARTHRITIS
por: Chandran, Vinod
Publicado: (2010)

The efficacy and safety of apremilast, etanercept and placebo in patients with moderate‐to‐severe plaque psoriasis: 52‐week results from a phase IIIb, randomized, placebo‐controlled trial (LIBERATE)
por: Reich, K., et al.
Publicado: (2016)

Cannot write session to /tmp/vufind_sessions/sess_m61hj150869ksmu4o8vllcnc5a